Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib

Abstract

Abstract Both bullous pemphigoid and mucous membrane pemphigoid are autoimmune bullous diseases that can be challenging to treat in individual cases. Janus kinase inhibitors have shown efficacy in several autoimmune and inflammatory diseases, although these drugs are not yet widely used in autoimmune bullous diseases. We report two recalcitrant cases of pemphigoid with mucous membrane involvement which were successfully treated with the JAK 1/2 inhibitor baricitinib after all other feasible therapeutic options had been exhausted.

Keywords

• baricitinib
• bullous pemphigoid
• Janus kinase inhibitor
• mucous membrane pemphigoid